Q73109336 | Abundant expression of CD40 and CD40-ligand (CD154) in paediatric Langerhans cell histiocytosis lesions |
Q36857660 | Activation and activation-induced death of human tonsillar B cells and Burkitt lymphoma cells: lack of CD95 (Fas/APO-1) ligand expression and function |
Q77627717 | Antigen-presenting cells in rheumatoid arthritis |
Q33682531 | Apoptosis in dendritic cell biology |
Q74592156 | Apoptosis in the immune system: 1. Fas-induced apoptosis in monocytes-derived human dendritic cells |
Q41211222 | Apoptosis-related mitochondrial dysfunction defines human monocyte-derived dendritic cells with impaired immuno-stimulatory capacities |
Q52119062 | Bcl-2, Bcl-xL and c-FLIP(L) potentially regulate the susceptibility of human peripheral blood monocyte-derived dendritic cells to cell death at different developmental stages. |
Q48747399 | Biological activity of interleukin-10 in the central nervous system |
Q36674462 | Biology of Langerhans cells and Langerhans cell histiocytosis |
Q35782771 | CD40 is a prognostic marker in primary cutaneous malignant melanoma. |
Q77513475 | CD40 is functionally expressed on human breast carcinomas: variable inducibility by cytokines and enhancement of Fas-mediated apoptosis |
Q54523129 | CD40 ligand inhibits Fas/CD95-mediated apoptosis of human blood-derived dendritic cells. |
Q34082784 | CD40-mediated regulation of immune responses by TRAF-dependent and TRAF-independent signaling mechanisms. |
Q24679736 | Cancer regression and autoimmunity induced by cytotoxic T lymphocyte-associated antigen 4 blockade in patients with metastatic melanoma |
Q43195283 | Collagen induces maturation of human monocyte-derived dendritic cells by signaling through osteoclast-associated receptor |
Q36368444 | Comparative analysis of genetically modified dendritic cells and tumor cells as therapeutic cancer vaccines |
Q39590913 | Consequences of Fas-mediated human dendritic cell apoptosis induced by measles virus. |
Q36642184 | Cytokine-mediated protection of human dendritic cells from prostate cancer-induced apoptosis is regulated by the Bcl-2 family of proteins |
Q36262281 | Dendritic cell dysfunction in cancer: a mechanism for immunosuppression |
Q42738684 | Dendritic cell maturation and survival are differentially regulated by TNFR1 and TNFR2. |
Q37771941 | Dendritic cell vaccines for the immunocompromised patient: prevention of influenza virus infection |
Q37448957 | Dendritic cell-based therapeutic cancer vaccines: what we have and what we need |
Q73933736 | Dendritic cells differently respond to haptens and irritants by their production of cytokines and expression of co-stimulatory molecules |
Q40819515 | Dendritic cells rapidly undergo apoptosis in vitro following culture with activated CD4+ Valpha24 natural killer T cells expressing CD40L. |
Q33653670 | Dendritic cells. |
Q33541092 | Dendritic cells: a novel therapeutic modality |
Q33890355 | Dendritic cells: immunological sentinels with a central role in health and disease. |
Q52182600 | Developmental regulation by cytokines of bone marrow-derived dendritic cells and epidermal Langerhans cells. |
Q37374541 | Functional CD40 ligand is expressed by T cells in rheumatoid arthritis |
Q74578839 | Granulocyte-macrophage colony-stimulating factor protects dendritic cells from liposome-encapsulated dichloromethylene diphosphonate-induced apoptosis through a Bcl-2-mediated pathway |
Q38883827 | HGF/Met Signaling in Head and Neck Cancer: Impact on the Tumor Microenvironment. |
Q41102414 | HIV: dendritic cells as embers for the infectious fire |
Q33888307 | IL-10 inhibits macrophage activation and proliferation by distinct signaling mechanisms: evidence for Stat3-dependent and -independent pathways |
Q47733677 | Immunocytochemical detection of cytokines and chemokines in Langerhans cells and in vitro derived dendritic cells. |
Q30448571 | Impaired accessory cell function in a human dendritic cell line after human immunodeficiency virus infection |
Q43974400 | In vivo gene transfer of CD40 ligand into colon cancer cells induces local production of cytokines and chemokines, tumor eradication and protective antitumor immunity |
Q42072317 | Increased Langerhans cell accumulation after mycobacterial stimuli |
Q73128944 | Induction of dendritic cell costimulator molecule expression is suppressed by T cells in the absence of antigen-specific signalling: role of cluster formation, CD40 and HLA-class II for dendritic cell activation |
Q28199765 | Induction, binding specificity and function of human ICOS |
Q53003813 | Induction, regulation, and function of soluble TRAP (CD40 ligand) during interaction of primary CD4+ CD45RA+ T cells with dendritic cells. |
Q58317003 | Inflammatory Lung Secretions Inhibit Dendritic Cell Maturation and Function via Neutrophil Elastase |
Q73174938 | Interleukin-10 prevents the generation of dendritic cells from human peripheral blood mononuclear cells cultured with interleukin-4 and granulocyte/macrophage-colony-stimulating factor |
Q40747726 | Interleukin-10 promotes B16-melanoma growth by inhibition of macrophage functions and induction of tumour and vascular cell proliferation. |
Q37375157 | Interleukin-10 promotes activation-induced cell death of SLE lymphocytes mediated by Fas ligand |
Q74419330 | Involvement of tumour necrosis factor-alpha-related apoptosis-inducing ligand in enhanced cytotoxicity of lipopolysaccharide-stimulated dendritic cells to activated T cells |
Q77892088 | Langerhans cells and chemical allergy |
Q37120379 | Mast cells condition dendritic cells to mediate allograft tolerance |
Q36753447 | Method for the validation of immunohistochemical staining using SCID mouse xenografts: expression of CD40 and CD154 in human non-small cell lung cancer |
Q43744460 | Modulation of phenotype, cytokine production and stimulatory function of CD34+-derived DC by NiCl(2) and SDS. |
Q52191696 | Monocyte-derived dendritic cells represent a transient stage of differentiation in the myeloid lineage. |
Q87732051 | Natural killer T cells are essential for the development of contact hypersensitivity in BALB/c mice |
Q24551158 | Natural selection of tumor variants in the generation of "tumor escape" phenotypes |
Q40906220 | Origin, maturation and antigen presenting function of dendritic cells. |
Q44604244 | Poly(I:C)-Treated human langerhans cells promote the differentiation of CD4+ T cells producing IFN-gamma and IL-10. |
Q48623108 | Preclinical assessment of anti-CD40 Mab 5D12 in cynomolgus monkeys |
Q36888465 | Profoundly Reduced CD1c+ Myeloid Dendritic Cell HLA-DR and CD86 Expression and Increased Tumor Necrosis Factor Production in Experimental Human Blood-Stage Malaria Infection |
Q35922431 | Progress in the development of immunotherapy of cancer using ex vivo-generated dendritic cells expressing multiple tumor antigen epitopes. |
Q34747476 | Proliferation and apoptosis in the developing human neocortex. |
Q36376879 | Regulation of B lymphocytes by dendritic cells. |
Q73265202 | Simple chemicals can induce maturation and apoptosis of dendritic cells |
Q73043181 | Split activity of interleukin-10 on antigen capture and antigen presentation by human dendritic cells: definition of a maturative step |
Q53946508 | TNF-alpha protects dendritic cells from prostate cancer-induced apoptosis. |
Q54312147 | TNF-α promotes IFN-γ-induced CD40 expression and antigen process in Myb-transformed hematological cells. |
Q52723984 | TNFα antagonism reveals a gut/lung axis that amplifies regulatory T cells in a pulmonary fungal infection. |
Q36380989 | TRANCE (tumor necrosis factor [TNF]-related activation-induced cytokine), a new TNF family member predominantly expressed in T cells, is a dendritic cell-specific survival factor |
Q37369953 | The biology of interleukin-2 efficacy in the treatment of patients with renal cell carcinoma |
Q42012073 | The enigmatic plasmacytoid T cells develop into dendritic cells with interleukin (IL)-3 and CD40-ligand |
Q41761209 | The immunosuppressive factors IL-10, TGF-β, and VEGF do not affect the antigen-presenting function of CD40-activated B cells |
Q41228239 | The role of cytokines in functional regulation and differentiation of dendritic cells |
Q40672082 | The sensitizer 2,4-dinitrofluorobenzene activates caspase-3 and induces cell death in a skin dendritic cell line |
Search more.